UBS keeps GSK at ‘neutral’ with focus on chief executive’s strategy update
UBS keeps GSK at ‘neutral’ with focus on chief executive’s strategy update Proactive uses images sourced from Shutterstock…
UBS keeps GSK at ‘neutral’ with focus on chief executive’s strategy update
UBS keeps GSK at ‘neutral’ with focus on chief executive’s strategy update Proactive uses images sourced from Shutterstock…
Novartis Strikes Deal With UK Biotech for Up To $1.7 Billion
Novartis AG will pay UK biotech Relation Therapeutics Ltd. as much as $1.7 billion to help find drug…
Novartis shells out $2 billion for immunology biotech Excellergy
A sign of Swiss pharmaceutical giant Novartis is seen on the top of a building at Novartis Campus…
Novartis, Roche could be most at risk
Medications are stored on shelves at a pharmacy on May 12, 2025 in Los Angeles, California. Eric Thayer…
Swiss drugmakers Novartis, Roche ditch some diversity programs
Sheldon Cooper | Lightrocket | Getty Images Swiss drugmaker Roche has abandoned global diverse workforce targets and compatriot…